Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"
- PMID: 32889105
- PMCID: PMC7462460
- DOI: 10.1016/j.tmaid.2020.101861
Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"
Comment on
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5. Travel Med Infect Dis. 2020. PMID: 32387409 Free PMC article.
Similar articles
-
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".Travel Med Infect Dis. 2020 Jul-Aug;36:101819. doi: 10.1016/j.tmaid.2020.101819. Epub 2020 Jul 3. Travel Med Infect Dis. 2020. PMID: 32629139 Free PMC article. No abstract available.
-
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.Travel Med Infect Dis. 2020 Jul-Aug;36:101791. doi: 10.1016/j.tmaid.2020.101791. Epub 2020 Jun 25. Travel Med Infect Dis. 2020. PMID: 32593867 Free PMC article.
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5. Travel Med Infect Dis. 2020. PMID: 32387409 Free PMC article.
-
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20. Indian J Public Health. 2020. PMID: 32496241 Review.
-
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.Circulation. 2020 Jun 16;141(24):e906-e907. doi: 10.1161/CIRCULATIONAHA.120.047521. Epub 2020 Apr 8. Circulation. 2020. PMID: 32267732 Review. No abstract available.
Cited by
-
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19.Infect Chemother. 2021 Mar;53(1):166-219. doi: 10.3947/ic.2021.0303. Infect Chemother. 2021. PMID: 34409790 Free PMC article. Review.
References
-
- Matthieu Million, Jean-Christophe Lagier, Philippe Gautret, Philippe Colson, Pierre- Edouard Fournier, Sophie Amrane, Marie Hocquart, Morgane Mailhe, Vera Esteves- Vieira, Barbara Doudier, Camille Aubry, Florian Correard, Audrey Giraud-Gatineau, Yanis Roussel, Cyril Berenger, Nadim Cassir, Piseth Seng, Christine Zandotti, Catherine Dhiver, Isabelle Ravaux, Christelle Tomei, Carole Eldin, Hervé Tissot- Dupont, Stéphane Honoré, Andreas Stein, Alexis Jacquier, Jean-Claude Deharo, Eric Chabrière, Anthony Levasseur, Florence Fenollar, Jean-Marc Rolain, Yolande Obadia, Philippe Brouqui, Michel Drancourt, Bernard La Scola, Philippe Parola, Didier Raoult Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Trav Med Infect Dis. 10.1016/j.tmaid.2020.101738. - DOI - PMC - PubMed
-
- Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., the Northwell Covid-19 Research Consortium, Barnaby D.P., Becker L.B., Chelico J.D., Cohen S.L., Cookingham J., Coppa K., Diefenbach M.A., Dominello A.J., Duer-Hefele J., Falzon L., Gitlin J., Hajizadeh N., Harvin T.G., Hirschwerk D.A., Kim E.J., Kozel Z.M., Marrast L.M., Mogavero J.N., Osorio G.A., Qiu M., Zanos T.P. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. J Am Med Assoc. 2020 Apr 22 doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
-
- Mercuro Nicholas J., Yen Christina F., Shim David J., Maher Timothy R., McCoy Christopher M., Zimetbaum Peter J., Gold Howard S. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019. COVID-19) JAMA Cardiol. Published online. May 1, 2020 doi: 10.1001/jamacardio.2020.1834. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources